Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Indolent B-Cell Non-Hodgkin Lymphoma · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
B-Cell Malignant Neoplasm
B-Cell Non-Hodgkin Lymphoma
Mature B-Cell Non-Hodgkin Lymphoma
Indolent B-Cell Non-Hodgkin Lymphoma

Hematologic Malignancy

Indolent B-Cell Non-Hodgkin Lymphoma

CI-CAN-00005561Explore in graph →

Hematologic172 active trials6 approved drugs2 evidence items

NCIt: C171299

Overview
Statistics
Survival
Genomics
Variants & evidence2
Drugs3
Trials617
Research
Rankings
Sources & provenance

Data completeness4 / 7 dimensions

Epidemiology (no data yet)
Survival (no data yet)
Trials (data present)
Literature (data present)
Genomics (no data yet)
Evidence (data present)
Therapies (data present)

Computed from entity_counters.completeness · refreshed after each connector run

Definition

What this entity is

A B-cell non-Hodgkin lymphoma with an indolent clinical course. Representative examples include grade 1 and grade 2 follicular lymphoma, marginal zone lymphoma, and lymphoplasmacytic lymphoma.

Definition text as published by ncit-evsProvenance

Source: NCI Thesaurus (NCIt)
Dataset: NCI Thesaurus
Version: 26.08e
Retrieved: Sep 8, 2026
Layer: raw (as published)
Evidence: expert curation
License: CC BY 4.0
Run: ING-NCITEVS-20260908-000001

Open at source Curated

Data updated 22 days agoSource updated 26.08e

Taxonomy

Position in the hierarchies

Several hierarchies coexist; edges are listed per hierarchy type with their source.

Parents

ncit

Indolent Non-Hodgkin LymphomaHematologic Malignancy
Mature B-Cell Non-Hodgkin LymphomaHematologic Malignancy

Children (7)

ncit

Grade 1 Follicular Lymphoma3 sub
Grade 2 Follicular Lymphoma3 sub
Lymphoplasmacytic Lymphoma4 sub
Marginal Zone Lymphoma7 sub
Primary Cutaneous Follicle Center Lymphoma
Primary Uveal Non-Hodgkin Lymphoma3 sub
Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation

Anatomy

Anatomical sites

Hematopoietic and Lymphatic SystemC35813

Record

Identity

CancerIndex ID: CI-CAN-00005561
Entity type: Hematologic Malignancy
Malignant: Yes
Solid / hematologic: Hematologic
Pediatric relevant: Not flagged
Rare cancer: Unknown (no incidence data yet)
Hierarchy depth: 6
Classification version: 26.08e
Semantic types: Neoplastic Process
Status: Active
Record updated: 2026-09-08

Coverage

Data completeness

Trials (all / active)

61 descendants in total; counters on this page aggregate over all of them.

617 / 172

Publications (all / 5y)

107 / 41

Evidence items

2

Genes / variants

1 / 1

Drugs (any / approved)

3 / 6

Genomic cohorts

0

Epidemiology / survival obs.

0 / 0

Data updated 17 hours agoSource updated unknowncounters aggregate over descendants

Names

Synonyms (0)

Only the preferred name is recorded so far.

CancerIndex is a research and information platform. It does not diagnose and does not recommend treatment.

Key figures

At a glance

Each figure carries its unit, period and source; ranks link to "Why this rank?".

US deaths19,882countUnited States · 2024 · both sexes · all agescdc-wonderObservedrank #8 of 31 (USA · both sexes · all ages · 2024 · top-level cancers)figures shown for Non-Hodgkin Lymphoma (registry level) — open Non-Hodgkin Lymphoma
US new cases75,946countUnited States · 2023 · both sexes · all agescdc-uscsObservedrank #8 of 32 (USA · both sexes · all ages · 2023 · top-level cancers)figures shown for Non-Hodgkin Lymphoma (registry level) — open Non-Hodgkin Lymphoma
US age-standardized mortality4.5per 100,000United States · 2024 · both sexes · all ages · 2000 U.S. Std. Populationcdc-wonderObservedrank #7 of 23 (USA · both sexes · all ages · 2024 · top-level cancers)figures shown for Non-Hodgkin Lymphoma (registry level) — open Non-Hodgkin Lymphoma
Active trials172countcurrent registry status · entity + descendantsclinicaltrialsComputedrank #149 of 1,654 (World · both sexes · all ages · latest · all malignant entities)
Recruiting trials84countstatus RECRUITING · entity + descendantsclinicaltrialsComputedrank #152 of 1,277 (World · both sexes · all ages · latest · all malignant entities)
Curated evidence items2countaccepted CIViC items · entity + descendantscivicComputedrank #342 of 492 (World · both sexes · all ages · latest · all malignant entities)
Publications, last 12 months14countPubMed records · stored query · 12-month windowpubmedComputedrank #854 of 2,294 (World · both sexes · all ages · latest · all malignant entities)
Genomic cohorts0countopen GDC projects · entity + descendantsgdcComputednot in a current ranking snapshot

Data updated 17 hours agoSource updated unknownregistry figures: cdc-uscs · latest year available per metric · counters aggregate over descendants